雅培(ABT)
icon
搜索文档
Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note
ZACKS· 2024-07-10 07:06
Abbott (ABT) closed at $101.64 in the latest trading session, marking a -0.47% move from the prior day. This change lagged the S&P 500's daily gain of 0.07%. Meanwhile, the Dow lost 0.13%, and the Nasdaq, a tech-heavy index, added 0.14%.The maker of infant formula, medical devices and drugs's shares have seen a decrease of 5% over the last month, not keeping up with the Medical sector's loss of 1.99% and the S&P 500's gain of 4.34%.The investment community will be closely monitoring the performance of Abbot ...
My Best Dividend Aristocrats For July 2024
Seeking Alpha· 2024-07-01 19:02
undefined/iStock via Getty Images 2024 Review A positive trajectory resumed for the ProShares S&P 500 Dividend Aristocrats ETF (NOBL) during the month of May. The ETF posted a modest gain of 1.45% during the month. Albeit some of this optimism has faded in June with the ETF sitting in the red near the end of the month. Year-to-date, through June 26th NOBL is up 2.44%. Several dividend aristocrats are running at a much faster pace than NOBL in 2024. Let's take a look at which individual aristocrats are drivi ...
3 MedTech Stocks to Buy for Healthy Gains
Investor Place· 2024-07-01 18:00
Fundamentally, few sectors exist outside of the broad healthcare umbrella that offer what I would term permanent relevance. In this case, the concept of caring for other people is likely an eternal one. So, it makes sense to consider medical technology or MedTech stocks to buy. As you know, the innovation ecosystem constantly moves in one direction: forward. It seems like every day, someone is talking about artificial intelligence or automated robotics or some invention in the connectivity arena. Enterprise ...
Abbott's (ABT) EPD Expansion Continues Despite FX Headwind
ZACKS· 2024-06-25 00:40
Abbott’s (ABT) diversified business portfolio is well-positioned to drive continued momentum in 2024. However, a challenging macroeconomic environment continues to dent Abbott’s business globally. The stock carries a Zacks Rank #3 (Hold) currently. Abbott continues to expand its Diagnostics business foothold (consisting of 22.2% of the total revenues in the first quarter of 2024). Over the past few quarters, the company has witnessed increased demand for routine diagnostics, particularly in the United State ...
Wall Street Analysts Think Abbott (ABT) Is a Good Investment: Is It?
ZACKS· 2024-06-24 22:35
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell- side) analysts often affect a stock's price, do they really matter? Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Abbott (ABT) . Abbott currently has an average brokerage recommendation ...
Abbott Teams Up With the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health
Prnewswire· 2024-06-20 20:05
Eight health centers across the U.S. participate in Innovation Incubator to find new ways to integrate healthy food into clinical care Now in its second year, the goal of the Innovation Incubator is to share what works with 1,400 health centers providing affordable care for 31+ million ABBOTT PARK, Ill. and BETHESDA, Md., June 20, 2024 /PRNewswire/ -- The global healthcare company Abbott (NYSE: ABT) and the National Association of Community Health Centers (NACHC) have joined together to increase access to h ...
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
The Motley Fool· 2024-06-20 17:15
These healthcare players offer you dividends and a strong earnings picture. When most of us think of winning in the stock market, we envision stocks in our portfolios gaining. And that's definitely a huge part of investment success. But over time, another element could greatly add to your gains: dividend payments. Dividend-paying stocks offer a source of recurrent income, boosting your portfolio regardless of the economic or stock-market environment. And even if a particular stock is in the doldrums, your l ...
Forget The S&P 500 - Here Are 3 Low-Risk, High-Quality Dividend Bargains I Like
Seeking Alpha· 2024-06-17 19:30
blinow61/iStock via Getty Images Introduction Index investing is great - especially if you're betting on the United States of America. Including dividends, over the past ten years, the S&P 500 has returned 235%, which translates to a 12.9% CAGR. During this period, the all-world (ex-U.S.) MSCI ETF (ACWX) returned 44%, which shows the massive benefit of investors investing in the United States. Data by YCharts In fact, the past 15 years have been exceptionally good for S&P 500 investors, as the index perform ...
Abbott Declares 402nd Consecutive Quarterly Dividend
Prnewswire· 2024-06-15 00:01
ABBOTT PARK, Ill., June 14, 2024 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 55 cents per share. This marks the 402nd consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 15, 2024, to shareholders of record at the close of business on July 15, 2024. Abbott has increased its dividend payout for 52 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that h ...
Abbott's (ABT) AVEIR DR Leadless Pacemaker System Gains CE Mark
ZACKS· 2024-06-12 22:45
Abbott (ABT) recently received a CE Mark in Europe for the AVEIR dual chamber (DR) leadless pacemaker system, the first ever dual chamber leadless pacemaker that treats people with abnormal or slow heart rhythms. The news follows the system’s FDA approval in June last year, shortly after late-breaking clinical data revealed that the AVEIR DR system met its three prespecified primary endpoints for safety and efficacy. The latest development is expected to significantly boost the company’s Cardiac Rhythm Mana ...